BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 25518507)

  • 1. [Pulmonary hypertension in Russia: the first results of the national register].
    Chazova IE; Arkhipova OA; Valieva ZS; Nakonechnikov SN; Martyniuk TV
    Ter Arkh; 2014; 86(9):56-64. PubMed ID: 25518507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Characteristics of patients with chronic thromboembolic pulmonary hypertension according to the Russian National Registry].
    Valieva ZS; Martynyuk TV; Nakonechnikov SN; Chazova IE
    Ter Arkh; 2021 Sep; 93(9):1058-1065. PubMed ID: 36286865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bosentan for patients with chronic thromboembolic pulmonary hypertension.
    Vassallo FG; Kodric M; Scarduelli C; Harari S; Potena A; Scarda A; Piattella M; Cassandro R; Confalonieri M
    Eur J Intern Med; 2009 Jan; 20(1):24-9. PubMed ID: 19237088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bosentan or Macitentan Therapy in Chronic Thromboembolic Pulmonary Hypertension?
    van Thor MCJ; Ten Klooster L; Snijder RJ; Kelder JC; Mager JJ; Post MC
    Lung; 2019 Dec; 197(6):753-760. PubMed ID: 31583452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute improved hemodynamics following inhaled iloprost in chronic thromboembolic pulmonary hypertension.
    Krug S; Hammerschmidt S; Pankau H; Wirtz H; Seyfarth HJ
    Respiration; 2008; 76(2):154-9. PubMed ID: 17804899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Features of clinical, functional and hemodynamics profile, medical treatment and prognosis evaluation in patients with inoperable chronic thromboembolic pulmonary hypertension and idiopathic pulmonary arterial hypertension according to the Russian registry].
    Chazova IE; Valieva ZS; Nakonechnikov SN; Taran IN; Martynyuk TV
    Ter Arkh; 2019 Sep; 91(9):77-87. PubMed ID: 32598818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and Instrumental Characteristics of Newly Diagnosed Patients with Various Forms of Pulmonary Hypertension according to the Russian National Registry.
    Chazova IY; Martynyuk TV; Valieva ZS; Gratsianskaya SY; Aleevskaya AM; Zorin AV; Nakonechnikov SN
    Biomed Res Int; 2020; 2020():6836973. PubMed ID: 32626754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of sarcoidosis-associated pulmonary hypertension: A single centre retrospective experience using targeted therapies.
    Keir GJ; Walsh SL; Gatzoulis MA; Marino PS; Dimopoulos K; Alonso R; Raposeiras-Roubin S; Renzoni EA; Maher TM; Wells AU; Wort SJ
    Sarcoidosis Vasc Diffuse Lung Dis; 2014 Jul; 31(2):82-90. PubMed ID: 25078636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bosentan for treatment of inoperable chronic thromboembolic pulmonary hypertension: BENEFiT (Bosentan Effects in iNopErable Forms of chronIc Thromboembolic pulmonary hypertension), a randomized, placebo-controlled trial.
    Jaïs X; D'Armini AM; Jansa P; Torbicki A; Delcroix M; Ghofrani HA; Hoeper MM; Lang IM; Mayer E; Pepke-Zaba J; Perchenet L; Morganti A; Simonneau G; Rubin LJ;
    J Am Coll Cardiol; 2008 Dec; 52(25):2127-34. PubMed ID: 19095129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The economic burden of chronic thromboembolic pulmonary hypertension in Russian Federation.
    Chazova IE; Martynyuk TV; Valieva ZS; Nakonechnikov SN; Nedogoda SV; Salasyuk AS; Taran IN; Gratsianskaya SE
    Ter Arkh; 2018 Sep; 90(9):101-109. PubMed ID: 30701743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medical and surgical management for chronic thromboembolic pulmonary hypertension: a single center experience.
    Coronel ML; Chamorro N; Blanco I; Amado V; Del Pozo R; Pomar JL; Badia JR; Rovira I; Matute P; Argemí G; Castellà M; Barberà JA
    Arch Bronconeumol; 2014 Dec; 50(12):521-7. PubMed ID: 24957814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic thromboembolic pulmonary hypertension (CTEPH): results from an international prospective registry.
    Pepke-Zaba J; Delcroix M; Lang I; Mayer E; Jansa P; Ambroz D; Treacy C; D'Armini AM; Morsolini M; Snijder R; Bresser P; Torbicki A; Kristensen B; Lewczuk J; Simkova I; Barberà JA; de Perrot M; Hoeper MM; Gaine S; Speich R; Gomez-Sanchez MA; Kovacs G; Hamid AM; Jaïs X; Simonneau G
    Circulation; 2011 Nov; 124(18):1973-81. PubMed ID: 21969018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic thromboembolic pulmonary hypertension.
    Hoeper MM; Madani MM; Nakanishi N; Meyer B; Cebotari S; Rubin LJ
    Lancet Respir Med; 2014 Jul; 2(7):573-82. PubMed ID: 24898750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Multicenter study of disease attributes in adult patients with pulmonary hypertension].
    Dong L; He JG; Liu ZH; Lu XL; Zeng WJ; Sun YJ; Ni XH; Gu Q; Zhao ZH; Cheng XS; Xiong CM
    Zhonghua Yi Xue Za Zhi; 2012 Apr; 92(16):1087-90. PubMed ID: 22781764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary arterial hypertension in Russia: six-year observation analysis of the National Registry.
    Chazova IE; Arkhipova OA; Martynyuk TV
    Ter Arkh; 2019 Mar; 91(1):24-31. PubMed ID: 31090367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Bosentan: a considerable increase in the survival of patients with pulmonary hypertension associated with systemic rheumatic diseases].
    Volkov AV; Iudkina NN; Nikolaeva EV; Kurmukov IA; Glukhova SI; Nasonov EL
    Ter Arkh; 2014; 86(5):32-9. PubMed ID: 25026800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiopulmonary exercise testing to evaluate the exercise capacity of patients with inoperable chronic thromboembolic pulmonary hypertension: an endothelin receptor antagonist improves the peak PETCO2.
    Hirashiki A; Adachi S; Nakano Y; Kono Y; Shimazu S; Shimizu S; Morimoto R; Okumura T; Takeshita K; Yamada S; Murohara T; Kondo T
    Life Sci; 2014 Nov; 118(2):397-403. PubMed ID: 24641953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary Arterial Hypertension-Specific Drug Therapy in COPD Patients with Severe Pulmonary Hypertension and Mild-to-Moderate Airflow Limitation.
    Calcaianu G; Canuet M; Schuller A; Enache I; Chaouat A; Kessler R
    Respiration; 2016; 91(1):9-17. PubMed ID: 26492415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Chronic thromboembolic pulmonary hypertension: Time delay from onset of symtoms to diagnosis and clinical condition at diagnosis].
    Held M; Grün M; Holl R; Walter F; Schäfers HJ; Graeter T; Wilkens H; Jany B
    Dtsch Med Wochenschr; 2014 Aug; 139(33):1647-52. PubMed ID: 25093951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The oxygen kinetic effect of inhaled iloprost in pulmonary artery hypertension and chronic thromboembolic pulmonary hypertension].
    Cui N; Yang YH; Xie WM; Ma ZH; Luo L; Wang C
    Zhonghua Jie He He Hu Xi Za Zhi; 2009 Jul; 32(7):522-6. PubMed ID: 19954007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.